Augmenting atypical antipsychotics with a cognitive enhancer (donepezil) improves regional brain activity in schizophrenia patients: a pilot double-blind placebo controlled BOLD fMRI study.

Augmenting atypical antipsychotics with a cognitive enhancer (donepezil) improves regional brain activity in schizophrenia patients: a pilot double-blind placebo controlled BOLD fMRI study. Neurocase. 2003 Jun; 9(3):274-82.

View in: PubMed

subject areas

Adult
Antipsychotic Agents
Cholinesterase Inhibitors
Cognition Disorders
Cross-Over Studies
Double-Blind Method
Drug Therapy, Combination
Humans
Indans
Magnetic Resonance Imaging
Male
Memory
Middle Aged
Outpatients
Piperidines
Placebos
Schizophrenia
Treatment Outcome

authors with profiles

Mark S George
Michael D. Horner
Xingbao Li